|
atherosclerosis |
19 |
|
humans |
19 |
|
adult |
17 |
|
male |
17 |
|
middle aged |
17 |
|
diffusion tensor imaging |
15 |
|
rheumatoid arthritis |
14 |
|
female |
13 |
|
dementia |
12 |
|
magnetic resonance imaging |
12 |
|
anisotropy |
11 |
|
brain - pathology |
11 |
|
delusional disorder |
10 |
|
f-dopa |
10 |
|
first-episode psychosis |
10 |
|
negative symptoms |
10 |
|
positron emission tomography |
10 |
|
schizophrenia |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
alzheimer's disease |
9 |
|
olfactory dysfunction |
9 |
|
resting-state fmri |
9 |
|
vitamin a |
9 |
|
aerosolised |
8 |
|
anosmia |
8 |
|
cardiovascular diseases |
8 |
|
case-control studies |
8 |
|
functional brain network |
8 |
|
imaging |
8 |
|
long covid |
8 |
|
multi-detector computed tomography |
8 |
|
neuromyelitis optica |
8 |
|
olfactory training |
8 |
|
prevalence |
8 |
|
quantitative susceptibility mapping |
8 |
|
risk factors |
8 |
|
smell loss |
8 |
|
aging |
7 |
|
diffusion tensor imaging - methods |
7 |
|
epidemiology |
7 |
|
hong kong |
7 |
|
medical sciences |
7 |
|
parkinson's disease |
7 |
|
public health |
7 |
|
tomography, spiral computed |
7 |
|
aging - pathology |
6 |
|
alff |
6 |
|
alzheimer disease - pathology |
6 |
|
aorta, thoracic - pathology - radiography |
6 |
|
aortic diseases - epidemiology - radiography |
6 |
|
arterial calcification |
6 |
|
arthritis, rheumatoid - complications |
6 |
|
atherosclerosis - epidemiology - physiopathology - radiography |
6 |
|
atherosclerosis - epidemiology - radiography |
6 |
|
biological markers - analysis |
6 |
|
body mass index |
6 |
|
c-reactive protein |
6 |
|
c-reactive protein - analysis |
6 |
|
calcinosis - complications - epidemiology - radiography |
6 |
|
calcinosis - epidemiology - physiopathology - radiography |
6 |
|
calcinosis - etiology - radiography |
6 |
|
cardiovascular diseases - epidemiology - physiopathology - radiography |
6 |
|
cardiovascular system - pathology - physiopathology - radiography |
6 |
|
carotid arteries - pathology - radiography |
6 |
|
carotid artery diseases - epidemiology - radiography |
6 |
|
carotid artery, common - radiography |
6 |
|
cerebral microbleeds |
6 |
|
cerebral small vessel disease |
6 |
|
computer tomography |
6 |
|
coronary artery disease |
6 |
|
coronary artery disease - etiology - radiography |
6 |
|
coronary vessels - pathology |
6 |
|
diffusivity |
6 |
|
dti |
6 |
|
fiber tracking |
6 |
|
functional connectivity |
6 |
|
functional mri |
6 |
|
intra-abdominal fat |
6 |
|
ischemic stroke |
6 |
|
logistic models |
6 |
|
lupus erythematosus, systemic - complications - physiopathology |
6 |
|
magnetic resonance spectroscopy |
6 |
|
multimodal |
6 |
|
nerve fibers, myelinated - pathology |
6 |
|
obesity |
6 |
|
obstructive sleep apnea |
6 |
|
regression analysis |
6 |
|
resting state |
6 |
|
retrogenesis |
6 |
|
scleroderma, systemic - complications - radiography |
6 |
|
sensitivity and specificity |
6 |
|
sleep apnea, obstructive - metabolism |
6 |
|
systemic lupus erythematosus |
6 |
|
vascular calcification |
6 |
|
visceral fat |
6 |
|
visual hallucinations |
6 |
|
visual spatial memory |
6 |
|
waist circumference |
6 |
|
white matter integrity |
6 |
|
aged |
5 |
|
amygdala |
5 |
|
calcinosis - pathology - radiography |
5 |
|
cerebral microbleed |
5 |
|
cervical spinal cord |
5 |
|
chronic kidney disease |
5 |
|
coronary angiography |
5 |
|
coronary artery disease - complications - radiography |
5 |
|
covid-19 |
5 |
|
hippocampus |
5 |
|
intracerebral hemorrhage |
5 |
|
iron deposition |
5 |
|
magnetic |
5 |
|
multiple sclerosis |
5 |
|
neuromyelitis optica - diagnosis - pathology |
5 |
|
renal impairment |
5 |
|
resonance imaging |
5 |
|
scleroderma, systemic - complications - pathology |
5 |
|
smell training |
5 |
|
spinal cord - pathology |
5 |
|
statistics, nonparametric |
5 |
|
adrenal cortex hormones - therapeutic use |
4 |
|
aged, 80 and over |
4 |
|
anterior cingulate cortex |
4 |
|
apoe ɛ4-negative |
4 |
|
apoe4 |
4 |
|
arterial spin labeling |
4 |
|
diffusional kurtosis imaging |
4 |
|
functional magnetic resonance imaging |
4 |
|
glutamatergic system |
4 |
|
late-onset alzheimer's disease |
4 |
|
low‐density lipoprotein cholesterol |
4 |
|
mlkl |
4 |
|
normal-appearing brain tissues |
4 |
|
positron-emission tomography - methods |
4 |
|
predictive value of tests |
4 |
|
prognosis |
4 |
|
prospective cohort study |
4 |
|
retrospective studies |
4 |
|
stroke |
4 |
|
whole exome sequencing |
4 |
|
american joint committee on cancer stages |
3 |
|
amyloidosis - diagnosis - etiology - pathology - radionuclide imaging |
3 |
|
basal ganglia |
3 |
|
biomarker |
3 |
|
brainstem atrophy |
3 |
|
brainstem regional volume |
3 |
|
calcinosis - etiology - radionuclide imaging |
3 |
|
carcinoma - radiotherapy |
3 |
|
cerebral blood flow |
3 |
|
cerebral infarction |
3 |
|
cerebral perfusion |
3 |
|
computed tomography |
3 |
|
corpus callosum |
3 |
|
cyclegan |
3 |
|
cyclophosphamide - therapeutic use |
3 |
|
deep learning |
3 |
|
diagnostic errors |
3 |
|
diffusion-weighted imaging |
3 |
|
disability |
3 |
|
discriminant analysis |
3 |
|
first-episode schizophrenia |
3 |
|
fluorodeoxyglucose f18 - pharmacology |
3 |
|
gamma-aminobutyric acid |
3 |
|
germinoma |
3 |
|
glutamate |
3 |
|
immunoglobulin lambda-chains - analysis |
3 |
|
immunosuppressive agents |
3 |
|
incidence |
3 |
|
lupus nephritis - diagnosis |
3 |
|
lymph nodes - pathology - radionuclide imaging |
3 |
|
lymphatic diseases - etiology - pathology - radionuclide imaging |
3 |
|
machine learning |
3 |
|
magnetic resonance imaging (mri) |
3 |
|
multiple sclerosis (ms) |
3 |
|
myelin |
3 |
|
nasopharyngeal carcinoma |
3 |
|
nasopharyngeal neoplasms - metabolism - radiotherapy |
3 |
|
neuromyelitis optica spectrum disorders |
3 |
|
neuromyelitis optica spectrum disorders (nmosd) |
3 |
|
neuropsychological assessment |
3 |
|
observer variation |
3 |
|
paraproteinemias - complications - diagnosis |
3 |
|
paraproteins - analysis |
3 |
|
positron emission tomography-computed tomography |
3 |
|
positron-emission tomography and computed tomography |
3 |
|
prospective studies |
3 |
|
proteinuria - drug therapy - etiology |
3 |
|
proton magnetic resonance spectroscopy |
3 |
|
psychiatry and neurology gerontology and geriatrics |
3 |
|
psychosis |
3 |
|
random forest |
3 |
|
relayed nuclear overhauser effect (rnoe) |
3 |
|
resnet |
3 |
|
severity of illness index |
3 |
|
silent lacunes |
3 |
|
single-blind method |
3 |
|
sjogren's syndrome - diagnosis - etiology - pathology |
3 |
|
standardized uptake value |
3 |
|
stroke - epidemiology |
3 |
|
tomography |
3 |
|
tomography, x-ray computed |
3 |
|
tomography, x-ray computed - methods |
3 |
|
total lesion glycolysis |
3 |
|
v-net |
3 |
|
vascular cognitive impairment |
3 |
|
white matter hyperintensities |
3 |
|
absolute quantification |
2 |
|
acute disease |
2 |
|
altitude |
2 |
|
altitude sickness |
2 |
|
analysis |
2 |
|
analysis of variance |
2 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
2 |
|
apparent diffusion coefficient |
2 |
|
arteriovenous anastomosis - pathology |
2 |
|
arteriovenous malformation |
2 |
|
asian continental ancestry group |
2 |
|
astrocytoma |
2 |
|
awake |
2 |
|
blood-brain barrier |
2 |
|
body burden |
2 |
|
body water |
2 |
|
brain cortex |
2 |
|
brain edema |
2 |
|
brain injuries - pathology |
2 |
|
brain ischemia - diagnosis - etiology |
2 |
|
brain ischemia - drug therapy - epidemiology - radiography |
2 |
|
brain ischemia - epidemiology |
2 |
|
brain malformation |
2 |
|
brain mapping |
2 |
|
brain neoplasms - blood supply - metabolism - pathology - secondary |
2 |
|
brain network |
2 |
|
brain tumor |
2 |
|
calcinosis - epidemiology - ethnology - radiography |
2 |
|
cancer risk |
2 |
|
capillary permeability |
2 |
|
carcinoma - blood supply - metabolism - pathology - secondary |
2 |
|
cauda equina |
2 |
|
cerebral arteries - pathology - physiopathology - radiography |
2 |
|
child |
2 |
|
child, preschool |
2 |
|
clinical outcome |
2 |
|
cognition disorders |
2 |
|
cohort studies |
2 |
|
comprehension - physiology |
2 |
|
coronary angiography - methods - statistics & numerical data |
2 |
|
cranioplasty |
2 |
|
ct coronary angiography |
2 |
|
decompressive craniectomy |
2 |
|
diffusion |
2 |
|
diffusion magnetic resonance imaging - methods |
2 |
|
disease progression |
2 |
|
dynamic contrast-enhanced mri |
2 |
|
electrocardiography - methods |
2 |
|
emission-computed |
2 |
|
epilepsy - diagnosis - pathology - radionuclide imaging |
2 |
|
extracellular matrix - pathology |
2 |
|
faux pas |
2 |
|
filum termniale |
2 |
|
fluorodeoxyglucose f18 |
2 |
|
frontal lesions |
2 |
|
frontal lobe - pathology - physiopathology |
2 |
|
functional prediction |
2 |
|
general anaesthesia |
2 |
|
glioblastoma - blood supply - metabolism - pathology |
2 |
|
glioma - blood supply - metabolism - pathology |
2 |
|
heart |
2 |
|
heart rate |
2 |
|
hemangioblastoma |
2 |
|
hemangioblastoma - blood supply - pathology - surgery |
2 |
|
hippocampal volumetry |
2 |
|
hong kong - epidemiology |
2 |
|
infarction, middle cerebral artery - drug therapy - epidemiology - radiography |
2 |
|
intracranial arteriosclerosis - epidemiology - ethnology - radiography |
2 |
|
intracranial atherosclerosis |
2 |
|
ischemia - pathology |
2 |
|
ischemic attack, transient - drug therapy - epidemiology - radiography |
2 |
|
ischemic attack, transient - epidemiology |
2 |
|
lymphoma, large b-cell, diffuse - diagnosis |
2 |
|
magnetic resonance imaging - methods |
2 |
|
medial frontal region |
2 |
|
medial temporal atrophy |
2 |
|
meningeal neoplasms - blood supply - metabolism - pathology |
2 |
|
meningioma - blood supply - metabolism - pathology |
2 |
|
mental state |
2 |
|
mental status schedule |
2 |
|
mentalizing |
2 |
|
meta& |
2 |
|
mild behavioural impairment |
2 |
|
mild cognitive impairment |
2 |
|
mixed dementia |
2 |
|
models, cardiovascular |
2 |
|
motor cortical mapping |
2 |
|
mr perfusion |
2 |
|
neoplasms, radiation-induced - epidemiology |
2 |
|
neuronal hypertrophy |
2 |
|
neuropsychological tests |
2 |
|
pediatric imaging |
2 |
|
perfusion |
2 |
|
peripheral nervous system neoplasms - blood supply - pathology - surgery |
2 |
|
perivascular spaces |
2 |
|
permeability |
2 |
|
phantoms, imaging |
2 |
|
positron-emission tomography |
2 |
|
posterior cingulate cortex |
2 |
|
radiation dosage |
2 |
|
radiation dose |
2 |
|
reproducibility of results |
2 |
|
rich-club organization |
2 |
|
risk assessment |
2 |
|
single-photon |
2 |
|
skin neoplasms - diagnosis |
2 |
|
small vessel disease |
2 |
|
social perception |
2 |
|
spinal avf |
2 |
|
stroke - diagnosis - etiology |
2 |
|
stroke recovery |
2 |
|
structural network |
2 |
|
subjective cognitive decline |
2 |
|
theory of mind - physiology |
2 |
|
thinking |
2 |
|
thrombolysis |
2 |
|
thrombolytic therapy |
2 |
|
tia |
2 |
|
tibet |
2 |
|
time factors |
2 |
|
tomography, emission-computed, single-photon/methods |
2 |
|
transient ischemic attack |
2 |
|
tumor microenvironment |
2 |
|
type 2 diabetes mellitus |
2 |
|
united states - epidemiology |
2 |
|
vascular dementia |
2 |
|
x-ray computed |
2 |
|
18f-flutemetamol |
1 |
|
1h mrs |
1 |
|
3.0 tesla |
1 |
|
adenocarcinoma - blood supply - metabolism - radiography |
1 |
|
adolescent |
1 |
|
alzheimer&apos |
1 |
|
alzheimer’s disease |
1 |
|
amyloid |
1 |
|
analyze 7.0 software |
1 |
|
angiography - methods |
1 |
|
angiography, digital subtraction |
1 |
|
arterial blood volume |
1 |
|
arterial transit time |
1 |
|
atypical |
1 |
|
biological markers - blood |
1 |
|
biopsy, needle |
1 |
|
blood flow velocity |
1 |
|
blood vessel prosthesis - statistics & numerical data |
1 |
|
blood volume |
1 |
|
brain |
1 |
|
brain ischemia - radiography |
1 |
|
brain neoplasms - complications - secondary |
1 |
|
brain stem - pathology |
1 |
|
brainstem |
1 |
|
carotid artery, internal - radiography |
1 |
|
carotid stenosis - radiography |
1 |
|
cerebral angiography |
1 |
|
cerebral infarction - epidemiology |
1 |
|
cerebrovascular circulation - drug effects |
1 |
|
china - epidemiology |
1 |
|
clinical trials as topic |
1 |
|
cognitively normal older adults |
1 |
|
colorectal neoplasm |
1 |
|
colorectal neoplasms - blood supply - metabolism - radiography |
1 |
|
comorbidity |
1 |
|
contraceptives, oral, hormonal - adverse effects |
1 |
|
diagnostic imaging |
1 |
|
dura mater - pathology |
1 |
|
early-onset alzheimer’s disease |
1 |
|
endosonography - methods |
1 |
|
epidemiologic factors |
1 |
|
gamma knife radiosurgery |
1 |
|
gastrointestinal hemorrhage - diagnosis - ultrasonography |
1 |
|
gastrointestinal stromal tumors - diagnosis - ultrasonography |
1 |
|
gonadal steroid hormones - physiology |
1 |
|
human immunodeficiency virus |
1 |
|
image processing, computer-assisted |
1 |
|
immunohistochemistry |
1 |
|
intracranial arteriosclerosis - epidemiology - surgery |
1 |
|
ischemic attack, transient - radiography |
1 |
|
lung neoplasms - complications |
1 |
|
manual hippocampal volumetry |
1 |
|
mass screening |
1 |
|
memory clinic |
1 |
|
microvessel density |
1 |
|
microvessels - pathology |
1 |
|
mri |
1 |
|
neovascularization, pathologic - radiography |
1 |
|
neurosyphilis |
1 |
|
perfusion imaging |
1 |
|
pituitary adenoma |
1 |
|
posterior leucoencephalopathy |
1 |
|
posterior leukoencephalopathy syndrome - chemically induced - pathology - radiography |
1 |
|
postoperative complications - epidemiology |
1 |
|
proto-oncogene proteins c-kit - blood |
1 |
|
quantitative medicine |
1 |
|
quasar |
1 |
|
reversible cerebral vasoconstriction syndrome |
1 |
|
risk assessment - methods |
1 |
|
s disease |
1 |
|
spm5 software with dartel registration |
1 |
|
stents - statistics & numerical data |
1 |
|
stroke - radiography |
1 |
|
therapeutic time window |
1 |
|
tumor control |
1 |
|
vascular endothelial growth factor |
1 |
|
vascular endothelial growth factor a - metabolism |
1 |
|
vasoconstriction - drug effects |
1 |
|
vbm |
1 |
|
vocal cord paralysis - etiology |
1 |
|
vocal fold paralysis |
1 |
|
voxel-based morphometry |
1 |
|
young adult |
1 |
